YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response

YAP is a transcriptional coactivator of the Hippo signaling pathway that has largely been studied for its role in the regulation of organ size during development. Several studies have shown that YAP is upregulated in cancer cells, and more recently in the T regulatory (Treg) subset of CD4+ cells. Th...

Full description

Bibliographic Details
Main Authors: Andriana Lebid, Liam Chung, Drew M. Pardoll, Fan Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00580/full
_version_ 1818851529442983936
author Andriana Lebid
Liam Chung
Drew M. Pardoll
Fan Pan
author_facet Andriana Lebid
Liam Chung
Drew M. Pardoll
Fan Pan
author_sort Andriana Lebid
collection DOAJ
description YAP is a transcriptional coactivator of the Hippo signaling pathway that has largely been studied for its role in the regulation of organ size during development. Several studies have shown that YAP is upregulated in cancer cells, and more recently in the T regulatory (Treg) subset of CD4+ cells. These observations suggest that the transcriptional co-activator may promote tumor persistence and progression. Here, we report that YAP also plays an immunoinhibitory role in CD8 T cells, especially in activated cytotoxic cells usually found in the tumor microenvironment. Our findings add further rationale for the development and use of pharmacologic inhibitors of YAP to treat cancer.
first_indexed 2024-12-19T07:06:28Z
format Article
id doaj.art-dd7f726e95fc49b081623008e9387c13
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-19T07:06:28Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-dd7f726e95fc49b081623008e9387c132022-12-21T20:31:17ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-04-011110.3389/fimmu.2020.00580524805YAP Attenuates CD8 T Cell-Mediated Anti-tumor ResponseAndriana LebidLiam ChungDrew M. PardollFan PanYAP is a transcriptional coactivator of the Hippo signaling pathway that has largely been studied for its role in the regulation of organ size during development. Several studies have shown that YAP is upregulated in cancer cells, and more recently in the T regulatory (Treg) subset of CD4+ cells. These observations suggest that the transcriptional co-activator may promote tumor persistence and progression. Here, we report that YAP also plays an immunoinhibitory role in CD8 T cells, especially in activated cytotoxic cells usually found in the tumor microenvironment. Our findings add further rationale for the development and use of pharmacologic inhibitors of YAP to treat cancer.https://www.frontiersin.org/article/10.3389/fimmu.2020.00580/fullCD8 T cellYAPtumorimmunesuppressionhippo
spellingShingle Andriana Lebid
Liam Chung
Drew M. Pardoll
Fan Pan
YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
Frontiers in Immunology
CD8 T cell
YAP
tumor
immunesuppression
hippo
title YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
title_full YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
title_fullStr YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
title_full_unstemmed YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
title_short YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
title_sort yap attenuates cd8 t cell mediated anti tumor response
topic CD8 T cell
YAP
tumor
immunesuppression
hippo
url https://www.frontiersin.org/article/10.3389/fimmu.2020.00580/full
work_keys_str_mv AT andrianalebid yapattenuatescd8tcellmediatedantitumorresponse
AT liamchung yapattenuatescd8tcellmediatedantitumorresponse
AT drewmpardoll yapattenuatescd8tcellmediatedantitumorresponse
AT fanpan yapattenuatescd8tcellmediatedantitumorresponse